Structure-based Design on Anticancer Drug Discovery

被引：0
|
作者：
Zhong, Haizhen Andrew [1 ]
机构：
[1] Univ Nebraska Omaha, Dept Chem, 6001 Dodge St, Omaha, NE 68182 USA
来源：
CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2020年 / 20卷 / 10期
关键词：
INHIBITORS;
D O I：
10.2174/156802662010200331100200
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：813 / 814
页数：2
相关论文
共 50 条
  • [21] Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
    Cheng, Tiejun
    Li, Qingliang
    Zhou, Zhigang
    Wang, Yanli
    Bryant, Stephen H.
    AAPS JOURNAL, 2012, 14 (01): : 133 - 141
  • [22] Progress in structure-based drug design against influenza A virus
    Du, Qi-Shi
    Wei, Hang
    Huang, Ri-Bo
    Chou, Kuo-Chen
    EXPERT OPINION ON DRUG DISCOVERY, 2011, 6 (06) : 619 - 631
  • [23] 2-Aminobenzothiazoles in anticancer drug design and discovery
    Huang, Guang
    Cierpicki, Tomasz
    Grembecka, Jolanta
    BIOORGANIC CHEMISTRY, 2023, 135
  • [24] Structure-Based and Ligand-Based Drug Design for HER 2 Receptor
    Huang, Hung-Jin
    Lee, Kuei-Jen
    Yu, Hsin Wei
    Chen, Chien-Yu
    Hsu, Chih-Ho
    Chen, Hsin-Yi
    Tsai, Fuu-Jen
    Chen, Calvin Yu-Chian
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2010, 28 (01) : 23 - 37
  • [25] Perspectives on Inhibiting -Amyloid Aggregation through Structure-Based Drug Design
    Mishra, Pankaj
    Ayyannan, Senthil R.
    Panda, Gautam
    CHEMMEDCHEM, 2015, 10 (09) : 1467 - 1474
  • [26] Structure-Based Drug Design and Optimization of Mannoside Bacterial FimH Antagonists
    Han, Zhenfu
    Pinkner, Jerome S.
    Ford, Bradley
    Obermann, Robert
    Nolan, William
    Wildman, Scott A.
    Hobbs, Doug
    Ellenberger, Tom
    Cusumano, Corinne K.
    Hultgren, Scott J.
    Janetka, James W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (12) : 4779 - 4792
  • [27] MolHyb: A Web Server for Structure-Based Drug Design by Molecular Hybridization
    Wang, Hao
    Pan, Xiaolin
    Zhang, Yueqing
    Wang, Xingyu
    Xiao, Xudong
    Ji, Changge
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2022, 62 (12) : 2916 - 2922
  • [28] Inhibitors of Xanthine Oxidase: Scaffold Diversity and Structure-Based Drug Design
    Luna, Giuseppe
    Dolzhenko, Anton V.
    Mancera, Ricardo L.
    CHEMMEDCHEM, 2019, 14 (07) : 714 - 743
  • [29] Gyrase ATPase Domain as an Antitubercular Drug Discovery Platform: Structure-Based Design and Lead Optimization of Nitrothiazolyl Carboxamide Analogues
    Jeankumar, Variam Ullas
    Renuka, Janupally
    Kotagiri, Sonali
    Saxena, Shalini
    Kakan, Shruti Singh
    Sridevi, Jonnalagadda Padma
    Yellanki, Swapna
    Kulkarni, Pushkar
    Yogeeswari, Perumal
    Sriram, Dharmarajan
    CHEMMEDCHEM, 2014, 9 (08) : 1850 - 1859
  • [30] One Size Does Not Fit All: The Limits of Structure-Based Models in Drug Discovery
    Ross, Gregory A.
    Morris, Garrett M.
    Biggin, Philip C.
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2013, 9 (09) : 4266 - 4274
12345